Ocrelizumab Modulates Both B and T Cell Immune Capacities in Multiple Sclerosis
Qi Wu, Mikel Gurrea‐Rubio, Q. Wang…·Yang Mao‐Draayer
This study examines how ocrelizumab affects B and T cell populations in MS patients, revealing changes in B cell subsets and T cell dynamics, along with altered signaling pathways.